Clinical Research on Treatment of Early Type-2 Diabetic Nephropathy with Antang Ⅰ Decoction

WANG Ping,SHAO Yu-wei,WU Qian-cheng,YUAN Jin-feng
DOI: https://doi.org/10.3969/j.issn.1000-2219.2010.01.007
2010-01-01
Abstract:Objective To observe the clinical effects of Antang Ⅰ Decoction,a prescription of traditional Chinese medicine,in the treatment of early type-2 diabetic nephropathy(DN).Methods Sixty cases of early DN were averagely randomized into treatment group and control group.Patients in treatment group were treated with Antang Ⅰ Decoction,one dose daily,and patients in control group with Calcium Dobesilate Capsule,500 mg,three times daily.A course of treatment was 8 weeks.Before and after treatment,clinical symptoms,fasting blood glucose(FBG) level,glycosylated hemoglobin A1c(GHbA1c),the renal color Doppler flow signals,urinary albumin excretion(UAE) and homeostasis model assessment insulin resistance(HOMA-IR) in both groups were observed.Results There was significant difference between treatment group and control group in clinical efficacy including the renal color Doppler flow signals,UAER and HOMA-IR;The FBG and HbA1c in all patients significantly decreased after treatment,while there was no significant difference between the two groups.Conclusion Antang Ⅰ Decoction can ameliorate symptoms and signs of early DN.Its mechanism might not directly correlate with reducing the level of blood glucose,but with other pathways such as improving insulin resistance.
What problem does this paper attempt to address?